A four-man audit team from May and Baker Plc. on January 14, 2016 visited the Centre. The objective of the audit was to assess the level of suitability of CDDDP laboratory for carrying out analytical testing for May & Baker Nigeria Plc. in line with WHO good practices for pharmaceutical quality control laboratories.
The audit was focused on the Quality Systems and Laboratory Controls associated with the Testing facility (CDDDP) to be used for analysis of pharmaceutical products. The audit however, was performed in accordance with May & Baker acceptable Quality Management System (QMS) for third party analysis and WHO Guideline for pharmaceutical quality Control laboratory set up.